Improving Equity in Oncology Clinical Trials: Challenges and Strategies for Setting Diversity Enrollment Goals | February 14, 2024 Share
Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials | November 14, 2023 Share
Interpreting Data from Dose-Finding Studies in Early Phase Oncology Trials to Determine the Optimal Dose | November 14, 2023 Share
Accelerating Investigation of New Therapies in Earlier Metastatic Treatment Settings | November 18, 2022 Share
2022 Annual Meeting: Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Clinical Trials | November 18, 2022 Share
2022 Annual Meeting: Supporting a Patient-Centric Approach to Dose Optimization in Oncology: The Essential Role of Patient-Reported Outcomes (PROs) | November 18, 2022 Share
Circulating Tumor DNA in Development of Therapies for Cancer: An Evidentiary Roadmap to an Early Endpoint for Regulatory Decision-Making | June 29, 2022 Share
